Revance Therapeutics Inc (NAS:RVNC)
$ 3.06 -0.02 (-0.65%) Market Cap: 319.43 Mil Enterprise Value: 618.80 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 67/100

Revance Therapeutics Inc (RVNC) Transcripts

  • 1